To further explore the controversial potential for extrahepatic replication of hepatitis C virus (HCV), the highly strand-specific rTth method of reverse transcriptase PCR was used to examine sera, liver, peripheral blood mononuclear cells, and other extrahepatic tissues from HCV-infected chimpanzees and humans. Positive-strand HCV RNA was present in the liver at approximately 10-fold-higher levels than negative-strand HCV RNA. No negative-strand RNA was detected in peripheral blood mononuclear cells or other extrahepatic tissues despite the presence of abundant positive-strand RNA. These data demonstrate that within the limits of sensitivity of this highly strand-specific reverse transcriptase PCR method, no extrahepatic replication of HCV was detected.
The replication of hepatitis C virus (HCV) in extrahepatic tissues, especially peripheral blood mononuclear cells (PBMC), is highly controversial, and yet whether extrahepatic replication occurs is a critical question with regard to transmission and pathogenesis. One of the problems of determining the tropism of HCV for other tissues is the very low levels of virus in infected individuals. HCV can be routinely detected only by reverse transcriptase PCR (RT-PCR). The presence of HCV RNA is not sufficient to demonstrate replication of HCV in other tissues, since viral RNA may be present because of contamination with plasma and/or adherence of circulating virus. Methods for the detection of negative-strand HCV RNA are controversial. Several reports indicate that the standard method for detection of negative-strand HCV RNA lacks sufficient strand specificity to answer biological questions (5, 8, 9, 14) . The lack of strand specificity is due to false priming of the incorrect strand during the cDNA step. With the high level of amplification provided by PCR, detection of the incorrect strand is not easily avoided.
We have recently described two methods to circumvent the problem of false priming and have used the methods to demonstrate the appearance of positive-and negative-strand HCV RNA following in vitro infection of primary chimpanzee hepatocytes (8) . The rTth method of RT-PCR provided 10,000-to 100,000-fold differentials between the detection of the correct and incorrect strands in assays for HCV positive-and negativestrand synthetic RNA. To further explore the possibility of extrahepatic replication of HCV, we have examined serum, liver, PBMC, and other extrahepatic tissues from HCV-infected chimpanzees and humans by using rTth RT-PCR for negative-and positive-strand HCV RNA.
Strand-specific RT-PCR. In our earlier studies, tagged RT-PCR was used for detection of negative-strand RNA and rTth RT-PCR was used for detection of positive-strand RNA (8) . In this study, the rTth method was used for the detection of both strands, because it is easier to perform and yields better strand specificity than tagged RT-PCR. With rTth RT-PCR, false priming of the incorrect strand is avoided by conducting cDNA synthesis at 70ЊC with the thermostable rTth RT. Strand specificity requires that no RT activity remain after cDNA synthesis when both primers are added for PCR amplification. In the rTth method, this was accomplished by chelating Mn 2ϩ and adding Mg 2ϩ , which results in DNA polymerase activity without significant RT activity.
To demonstrate the sensitivity and specificity of the assays, synthetic positive-and negative-strand HCV RNAs (nucleotides 1 to 582) were transcribed in vitro and purified extensively to remove DNA. RNA was diluted in normal cell RNA such that all samples contained 1 g of cell RNA. RT-PCR was performed by a modification of the previously described rTth (8) procedure for both positive-and negative-strand RNA. RNA in 10 l was layered with mineral oil and heated to 95ЊC for 1 min. The temperature was lowered to 70ЊC, and 10 l of preheated cDNA reaction mixture was added. The reaction mixture consisted of 10 mM Tris (pH 8.3), 90 mM KCl, 1 mM MnCl 2 , 200 M each deoxynucleoside triphosphate, 50 ng of cDNA primer, and 5 U of rTth (Perkin-Elmer Cetus). The temperature was dropped to 60ЊC for 2 min for annealing and then raised to 70ЊC for 15 min for the cDNA reaction. The temperature was held at 70ЊC until 40 l of a prewarmed buffer containing ethylene glycol-bis (␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA) (20 mM Tris [pH 8.3] , 200 mM KCl, 1.5 mM EGTA, 0.1% Tween 20, and 10% glycerol) was added to chelate the Mn 2ϩ and inactivate the RT activity of rTth. Reaction tubes were held at 70ЊC while 40 l of prewarmed PCR mixture (50 ng of forward PCR primer in 3.75 mM MgCl 2 ) was added. The PCR conditions consisted of an initial cycle at 94ЊC for 3.5 min; 35 to 45 cycles at 94ЊC for 1.3 min, 60ЊC for 2 min, and 72ЊC for 3 min; and a final extension cycle at 72ЊC for 7 min. For positive-strand RNA, the cDNA reverse primer was 5Ј-TCGCGACCCAACACTACTC-3Ј and the forward primer was 5Ј-GGGGGCGACACTCCACCA-3Ј. The same primers were used in reverse order for detection of negative-strand RNA. The amplified product spans nucleotides 15 to 274 of the 5Ј noncoding region of HCV. One-fifth of the first-round product was analyzed by agarose gel electrophoresis and Southern hybridization with a 32 P-labeled probe internal to the PCR primers.
Analysis of highly purified synthetic HCV RNA with the rTth RT-PCR assays for positive-and negative-strand RNA revealed 10,000-to 100,000-fold differentials between detection of the correct and incorrect strands of RNA. In the experiment whose results are depicted in Fig. 1 , the negativestrand assay detected negative-strand RNA at 1 fg and positive-strand RNA at 10 pg (Fig. 1A) , while the positivestrand assay detected positive-strand RNA at 0.1 fg and negative-strand RNA at 10 pg (Fig. 1B) . Either the detection of the incorrect strand is due to a lapse of strand specificity at levels 10,000-fold higher than required to detect the correct strand of RNA or it may reflect a trace contamination with the DNA of the transcriptional vector not removed by two rounds of DNase treatment and RNAzol extraction. This assay routinely yields a minimum of a 1,000-fold differential with synthetic RNA.
Analysis of chimpanzee and human sera for HCV positiveand negative-strand RNA. Sera from two acutely infected (ϫ186 and ϫ187) and three chronically infected (ϫ059, ϫ341, and ϫ174) chimpanzees were examined for HCV positive-and negative-strand RNA. The PCR titers for positive-strand RNA ranged from 10 2 to 10 5 PCR units per ml. The titers of RNA were extrapolated from the last dilution in which 10 l was positive multiplied by 100 for PCR units per milliliter. No negative-strand HCV RNA was detected in the chimpanzee sera even with undiluted sera (Table 1) . To determine whether negative-strand RNA might be present in sera having very high HCV RNA titers, two high-titer human sera were examined. One serum sample had titers of 10 6 and 10 2 PCR units per ml for positive-and negative-strand RNA, respectively. This serum sample was not routinely positive for negative-strand HCV RNA even with 10 l of undiluted sera. The other serum sample had titers of 10 7 and 10 4 PCR units per ml for positive-and negative strand RNA, respectively; however, for this serum sample, the negative-strand signal was very weak at both of the dilutions tested (10 Ϫ1 and 10 Ϫ2 dilutions). Since the differentials in titer between the positive-and negative-strand-RNA assays for these sera were of the same order of magnitude as was observed with positivestrand synthetic RNA, it cannot be concluded that negativestrand RNA was definitively present in sera (see ''Conclusions''). Detection of HCV positive-and negative-strand RNA in the livers of HCV-infected chimpanzees. To determine the level of positive-and negative-strand HCV RNA in the liver, biopsy samples were obtained from the five chimpanzees mentioned above. Dilutions of the liver RNA were assayed for positiveand negative-strand HCV RNA. For each liver sample, positive-strand HCV RNA was detected at a 10-fold-higher level than negative-strand HCV RNA (Fig. 2) . Higher levels of positive-strand RNA than negative-strand RNA have been observed in cells infected with other positive-strand RNA viruses.
Lack of detection of HCV negative-strand RNA in PBMC derived from HCV-infected chimpanzees and humans. To examine PBMC for the presence of negative-strand HCV RNA, PBMC were purified from the plasma of the five chimpanzees mentioned above. Serial dilutions of PBMC RNA were tested for the presence of positive-and negative-strand RNA. Positive-strand RNA could be detected in the dilution of PBMC RNA containing 10 ng of RNA for ϫ187 and 1 g of RNA for the remaining four animals (Fig. 3) . No negative-strand RNA was detected in any of the dilutions of PBMC RNA. Since a 10-fold-lower level of HCV negative-strand RNA than positive-strand RNA was detected in the liver RNA of the same animals, detection of negative-strand RNA may have been expected only in the PBMC RNA of ϫ187, in which case the a RNA was purified from 10-fold dilutions of chimpanzee (Ch) and human (HS) sera prepared in fetal bovine serum. HS1 was a gift from Paul Holland and Ken Quramoto and has been previously described (8) . HS2 was a gift from Robert Purcell and is the original H strain inoculum of HCV (2) .
b rTth RT-PCR was performed for both positive-strand (ϩRNA) and negative-strand (ϪRNA) HCV RNA by using RNA prepared from 10 l of each serial dilution. The PCR products were detected by Southern hybridization. Titers were extrapolated from the last dilution in which 10 l was positive for PCR multiplied by 100 for a PCR titer per milliliter of sera.
level of positive-strand RNA was sufficiently high to expect detection of negative-strand RNA.
To extend these observations to HCV-infected humans, PBMC RNA was purified from 10 HCV-infected individuals. In general, higher levels of positive-strand RNA were detected in human PBMC than in chimpanzee PBMC. Positive-strand HCV RNA was detected at titers of 10 3 PCR units per g of PBMC RNA for two of the PBMC samples, 10 2 PCR units per g of PBMC RNA for three of the PBMC samples, and 10 1 PCR units per g of PBMC RNA for two of the PBMC samples. No positive-strand RNA was detected in the RNA from three of the PBMC preparations. No negative-strand RNA was detected in any of the PBMC RNA preparations (Table 2 and Fig. 4) . If positive-strand RNA were present at 10-fold-higher levels than negative-strand RNA, as in the liver, negative-strand RNA should have been detectable in five of the PBMC samples. If present, negative-strand RNA must have been at a level at least 1,000-fold lower than that of positive-strand RNA for the two PBMC samples with the highest titers of positive-strand RNA.
Analysis of extrahepatic tissues for the presence of HCV positive-and negative-strand RNA. To extend the observations to other extrahepatic tissues, multiple tissues were obtained from a chimpanzee that was euthanized for humanitarian reasons because of kidney failure. The kidney failure may have been due to long-term HCV infection (6, 7, 12) . Tissues were obtained precisely at the time of death and frozen in liquid nitrogen. Serial dilutions of liver RNA were examined, while all other tissues were analyzed at 1 g of RNA per PCR. An intense reaction for positive-strand RNA was obtained with 10 ng of liver RNA. For all other tissues, positive-strand RNA was detected from 1 g of RNA with various degrees of intensity (Fig. 5) . The reactions for the spleen, muscle, and lymph nodes were the most intense. The pancreas and kidney were weakly positive with a short exposure of the autoradiogram (4 h [ Fig.   FIG. 2 . Detection of positive-and negative-strand HCV RNA in chimpanzee liver RNA. Total cell RNA was purified from liver biopsy samples from three chronically HCV-infected chimpanzees (ϫ059, ϫ174, and ϫ341) and two chimpanzees during acute infection (ϫ186 and ϫ187). Tenfold dilutions of liver RNA were prepared in normal cell RNA to yield samples with 1,000 to 1 ng of liver RNA and 1 g of normal cell RNA per 10 l. All assays included several negative controls consisting of normal cellular RNA. In addition, assays were controlled by amplification of 1 or 10 fg of the correct strand (sensitivity control) and 100 fg of the incorrect strand (specificity control) of synthetic HCV RNA (Syn RNA). Serum, plasma, and liver needle biopsy samples were taken by standard methods under a protocol approved by the institutional animal research committee. FIG. 3 . Lack of detection of negative-strand HCV RNA in PBMC from chimpanzees infected with HCV. PBMC were prepared from the same chimpanzees described in the legend to Fig. 2 , and dilutions of the PBMC RNA were subjected to strand-specific RT-PCR for HCV positive-strand (ϩRNA) and negative-strand (ϪRNA) RNA. PBMC were isolated on Histopaque 1077, and the PBMC layer was washed three times with serum-free RPMI 1640. 5A]), while detection of the reaction for PBMC and bone marrow required a longer exposure (data not shown). Negative-strand RNA was not detected in any tissue other than liver, which was positive with 100 ng of RNA (Fig. 5B) . These data are consistent with the virus being present in other tissues because of contamination with serum.
Conclusions. Whether extrahepatic replication occurs is an important question with regard to the transmission and pathogenesis of HCV infections. Several investigations have reported the detection of HCV negative-strand RNA in PBMC (3, 4, 10, 11, 13, 15) , with detection of high levels of negativestrand RNA in plasma in approximately 50% of the studies. In most instances, the differentials, if determined, between negative-and positive-strand RNA in PBMC and sera were 10-to 100-fold. In this study, PBMC from 10 humans chronically infected with HCV were examined. For the PBMC from five of these patients, the level of positive-strand RNA was quite high yet no negative-strand RNA could be detected. The data suggest that if negative-strand RNA were present in these PBMC, it was present at 100-to 1,000-fold-lower levels than positivestrand RNA.
The potential for extrahepatic replication was also examined in a series of tissues from a chimpanzee chronically infected with HCV. Low levels of positive-strand RNA were detected in all tissues examined, but no negative-strand RNA was detected. The detection of positive-strand RNA in all tissues in the absence of detectable negative-strand RNA suggests that the positive-strand RNA may be due to contamination with circulating virus.
Although these data do not exclude the potential for replication of HCV in extrahepatic tissue, they do suggest that several criteria should be met in order to determine whether replication occurs. First, titration assays should be performed with synthetic RNA in the presence of a high level of heterologous RNA to determine the degree of strand specificity and the level of sensitivity for the RT-PCR assay being employed. Second, the cellular RNA samples should be titrated to determine the endpoints of detection for positive-and negativestrand RNA and thus the ratio of negative-to positive-strand RNA. Negative-strand RNA must be detected at a level higher FIG. 4 . Lack of detection of negative-strand HCV RNA in PBMC from humans infected with HCV. PBMC RNA was purified, diluted in normal cell RNA, and subjected to strand-specific RT-PCR for positive-strand (ϩRNA) and negative-strand (ϪRNA) HCV RNA. PBMC were obtained from 10 patients with chronic HCV infection. The diagnosis of chronic infection was based on standard clinical parameters and serological assays. All patients were anti-HCV antibody positive as determined by the second-generation (c200/c22-3) HCV ELISA test system (Ortho Diagnostics, Inc., Raritan, N.J.) as previously described (1) . PBMC were separated on Ficoll-Hypaque density gradients, washed three times in Hank's balanced salt solution, and resuspended with RPMI 1640 as previously described (1) . Peripheral blood lymphocyte (PBL) samples correspond to the PBMC samples in Table 2 . Fig. 2 . Liver RNA (Lv) was examined at 100 and 10 ng for positivestrand HCV RNA (A) and at 1,000 to 10 ng for negative-strand HCV RNA (B). RNA samples from other tissues were examined at 1,000 ng, including spleen (Sp), pancreas (Pn), kidney (Kd), muscle (Mu), lymph node (LN), bone marrow (BM), and PBL. Positive-strand (ϩ) and negative-strand (Ϫ) synthetic HCV RNAs (Syn RNA) were included as controls for strand specificity and sensitivity, as described in the legend to Fig. 2. 
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